Clinical Trials Logo

Menstrual Cycle Abnormal clinical trials

View clinical trials related to Menstrual Cycle Abnormal.

Filter by:
  • None
  • Page 1

NCT ID: NCT06339476 Completed - Clinical trials for Menstrual Irregularity

Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

A cross-sectional study design was employed, involving 56 premenopausal participants with ages ranging from 20 to 49 years. Serum samples were collected during the early follicular phase, and levels of some biochemicals parameters analyzed.

NCT ID: NCT06227676 Completed - Clinical trials for Polycystic Ovary Syndrome

Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25

NUTRITION; GYN
Start date: July 21, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

85 percent of women of reproductive age experience consistent period cramps/menstrual pain, and 60% indicate that they do not use painkillers to relieve menstrual symptoms; there is a need for natural and non-medicative supplements to dysmenorrhea. The purpose of this clinical trial is to examine the effect of 'Cramp Bites'--classified by a mixture of natural ingredients researched to help with period pain--on women suffering from primary dysmenorrhea: this will be done through providing participants with the snack and surveying them on how it changes their period symptoms.

NCT ID: NCT05936840 Not yet recruiting - Clinical trials for Polycystic Ovary Syndrome

Quantum Menstrual Health Monitoring Study

QMHMS
Start date: September 13, 2023
Phase:
Study type: Observational

The Quantum Menstrual Health Monitoring Study will measure four key reproductive hormones in the urine to characterize patterns that predict and confirm ovulation, referenced to serum hormones and the gold-standard of the ultrasound day of ovulation in participants with regular cycles. These normal cycles will provide a reference for comparison to irregular cycles in polycystic ovarian syndrome (PCOS) and athletes. Clinical signs in the menstrual cycle (e.g. menstrual bleeding, temperature) as well as vital sign and sleep patterns will also be referenced to hormonal changes.

NCT ID: NCT05812209 Completed - Pain Clinical Trials

Stellate Ganglion Block to Treat Long COVID 19 Case Series

Start date: September 1, 2022
Phase:
Study type: Observational

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

NCT ID: NCT04251559 Completed - Clinical trials for Diabetes, Gestational

Evaluation of Risk Factors for Gestational Diabetes Mellitus

Start date: January 1, 2014
Phase: N/A
Study type: Interventional

This study examines the relationship between the age at menarche and gestational diabetes mellitus (GDM). In this retrospective study, the sample included all pregnant women diagnosed with GDM in a pregnancy polyclinic in Kocaeli, Turkey between 2014 and 2019. The sample included 373 participants: 233 in the GDM group and 140 in the control group. The groups were compared in terms of age at menarche.

NCT ID: NCT03951194 Recruiting - Infertility, Female Clinical Trials

Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women

PRP
Start date: June 13, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Autologous PRP intra ovarian infusion may improve ovarian response and women's hormonal profile and may promote folliculogenesis in perimenopausal women.

NCT ID: NCT03306849 Completed - Obesity Clinical Trials

Ultrasonographic Evaluation of Anovulatory Disorders in Lean and Overweight Women

Start date: August 2015
Phase:
Study type: Observational

The investigators would like to determine whether ultrasound features of the ovaries can be used to reliably diagnose different types of anovulatory disorders in women across all body types. The study will also try to establish whether ultrasound features of the ovary can reflect the degree of reproductive and metabolic problems that a woman with irregular or absent periods might be experiencing.